Literature DB >> 26936105

Renin-Angiotensin System Inhibitors: Do They Have the Same Impact at All Ages?

Konstantinos P Imprialos1, Chrysoula Boutari1, Konstantinos Stavropoulos1, Erasmia Sampani2, Asterios I Karagiannis1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 26936105      PMCID： PMC8031665          DOI： 10.1111/jch.12809

Source DB:  PubMed          Journal:  J Clin Hypertens (Greenwich)        ISSN： 1524-6175            Impact factor:   3.738


× No keyword cloud information.
  6 in total

Review 1.  Effects of different regimens to lower blood pressure on major cardiovascular events in older and younger adults: meta-analysis of randomised trials.

Authors:  F Turnbull; B Neal; T Ninomiya; C Algert; H Arima; F Barzi; C Bulpitt; J Chalmers; R Fagard; A Gleason; S Heritier; N Li; V Perkovic; M Woodward; S MacMahon
Journal:  BMJ       Date:  2008-05-14

2.  Management of hypertension: summary of NICE guidance.

Authors:  Taryn Krause; Kate Lovibond; Mark Caulfield; Terry McCormack; Bryan Williams
Journal:  BMJ       Date:  2011-08-25

3.  Double-blind, placebo-controlled crossover comparison of five classes of antihypertensive drugs.

Authors:  Alison J Deary; Anne L Schumann; Helen Murfet; Stephen F Haydock; Roger S-Y Foo; Morris J Brown
Journal:  J Hypertens       Date:  2002-04       Impact factor: 4.844

4.  Optimisation of antihypertensive treatment by crossover rotation of four major classes.

Authors:  J E Dickerson; A D Hingorani; M J Ashby; C R Palmer; M J Brown
Journal:  Lancet       Date:  1999-06-12       Impact factor: 79.321

5.  ACE inhibitors, beta-blockers, calcium blockers, and diuretics for the control of systolic hypertension.

Authors:  T O Morgan; A I Anderson; R J MacInnis
Journal:  Am J Hypertens       Date:  2001-03       Impact factor: 2.689

6.  Patients With Newly Diagnosed Hypertension Treated With the Renin Angiotensin Receptor Blocker Azilsartan Medoxomil vs Angiotensin-Converting Enzyme Inhibitors: The Prospective EARLY Registry.

Authors:  Roland E Schmieder; Sebastian A Potthoff; Peter Bramlage; Peter Baumgart; Felix Mahfoud; Hartmut Buhck; Taoufik Ouarrak; Martina Ehmen; Jochen Senges; Anselm K Gitt
Journal:  J Clin Hypertens (Greenwich)       Date:  2015-06-24       Impact factor: 3.738
  6 in total
  1 in total

1.  Is Azilsartan More Effective in Younger Than in Older Patients? An Explorative Analysis of the Prospective EARLY Registry.

Authors:  Roland E Schmieder; Peter Bramlage
Journal:  J Clin Hypertens (Greenwich)       Date:  2016-03-03       Impact factor: 3.738
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.